RELATIVE MUTAGENICITY AND TERATOGENICITY OF CYCLOPHOSPHAMIDE AND 2 OF ITS STRUCTURAL ANALOGS

被引：14

作者：

HALES, BF ^{[1
]}

机构：

[1] MCGILL UNIV,MCGILL CTR STUDY REPROD,MONTREAL H3G 1Y6,QUEBEC,CANADA

来源：

关键词：

D O I：

10.1016/0006-2952(83)90151-X

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：3791 / 3795

页数：5

共 24 条

[1] ALARCON RA, 1972, CANCER RES, V32, P2519
[2] METHODS FOR DETECTING CARCINOGENS AND MUTAGENS WITH SALMONELLA-MAMMALIAN-MICROSOME MUTAGENICITY TEST
AMES, BN
MCCANN, J
YAMASAKI, E
[J]. MUTATION RESEARCH, 1975, 31 (06): : 347 - 363
[3] ARNOLD H, 1961, ARZNEIMITTEL-FORSCH, V11, P143
[4] BROCK N, 1979, ARZNEIMITTEL-FORSCH, V29-1, P659
[5] BROCK N, 1976, CANCER TREAT REP, V60, P301
[6] BROCK N, 1977, Zeitschrift fuer Krebsforschung und Klinische Onkologie, V88, P185
[7] CLAUSSEN U, 1980, ARZNEIMITTEL-FORSCH, V30-2, P2080
[8] SOME STUDIES OF ACTIVE INTERMEDIATES FORMED IN MICROSOMAL METABOLISM OF CYCLOPHOSPHAMIDE AND ISOPHOSPHAMIDE
CONNORS, TA
COX, PJ
FARMER, PB
FOSTER, AB
JARMAN, M
[J]. BIOCHEMICAL PHARMACOLOGY, 1974, 23 (01) : 115 - 129
[9] CYCLOPHOSPHAMIDE CYSTITIS - IDENTIFICATION OF ACROLEIN AS THE CAUSATIVE AGENT
COX, PJ
[J]. BIOCHEMICAL PHARMACOLOGY, 1979, 28 (13) : 2045 - 2049
[10] COX PJ, 1976, ADV MASS SPECTROM, V1, P59